Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2022-06-13 Notice of Dividend Amou…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
普莱柯2021年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2021 annual dividend distribution by 普莱柯生物工程股份有限公司. It details the dividend per share, relevant dates for dividend distribution, tax treatment for different shareholders, and the method of dividend payment. It references the approval of the dividend plan at the 2022 shareholders meeting but does not contain financial statements or comprehensive financial performance data. The document is focused on dividend amount and payment details, which fits the category of Notice of Dividend Amount (DIV). The document length is under 5,000 characters and is a formal announcement of dividend distribution, not a full annual report or financial statement.
2022-06-13 Chinese
北京德恒律师事务所关于普莱柯生物工程股份有限公司差异化分红事项之法律意见
Regulatory Filings
2022-06-13 Chinese
北京德恒律师事务所关于普莱柯生物工程股份有限公司2021年度股东大会的法律意见
Regulatory Filings
2022-05-19 Chinese
普莱柯2021年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a "2021 Annual General Meeting Resolution Announcement" for the company 普莱柯生物工程股份有限公司. It details the date and location of the AGM, attendance, voting results on various proposals including the 2021 annual report, board and supervisory reports, financial statements, profit distribution, and other corporate matters. It also includes legal witness statements confirming the legality and validity of the meeting and resolutions. The document is a formal announcement of the voting results and resolutions passed at the AGM, rather than the full annual report or financial statements themselves. The length is about 4096 characters, consistent with an announcement rather than a full report. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-05-19 Chinese
普莱柯关于非公开发行股票申请获得中国证监会发审会审核通过的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the approval of a non-public stock issuance application by the China Securities Regulatory Commission (CSRC). It mentions the approval of a non-public issuance of A shares and states that the company will announce again upon receiving formal approval documents. The content focuses on financing activity and capital structure changes, specifically a non-public stock issuance. The document is short (405 characters) and is an announcement of approval, not a detailed report or financial statement. Therefore, it fits best under Capital/Financing Update (CAP).
2022-05-16 Chinese
普莱柯2021年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled '2021 年度股东大会会议资料' which translates to '2021 Annual General Meeting (AGM) Meeting Materials'. It contains detailed information about the organization, agenda, voting procedures, and various reports to be discussed at the 2021 AGM of the company 普莱柯生物工程股份有限公司. The content includes the meeting agenda, voting instructions, and summaries of reports such as the 2021 annual report, board work report, supervisory board report, and independent director's report, all typical materials prepared for an AGM. There is no indication that this is the full annual report itself, but rather the materials prepared for the AGM. The document length is substantial (15,000 characters), consistent with detailed AGM materials. Therefore, this document fits the category of AGM Information (AGM-R).
2022-05-12 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.